Benefit, recurrence pattern, and toxicity to adjuvant anti-PD-1 monotherapy varies by ethnicity and melanoma subtype: An international multicenter cohort study by Bai, Xue, MD, Lawless, Aleigha R., BS, Czapla, Juliane A., MS, Gerstberger, Stefanie C., MD, PhD, Park, Benjamin C., MD, Jung, Seungyeon, BA, Johnson, Rebecca, MN, Yamazaki, Naoya, MD, PhD, Ogata, Dai, MD, PhD, Umeda, Yoshiyasu, MD, Li, Caili, MB, Guo, Jun, MD, PhD, Flaherty, Keith T., MD, Nakamura, Yasuhiro, MD, PhD, Namikawa, Kenjiro, MD, PhD, Long, Georgina V., MBBS, PhD, Menzies, Alexander M., MBBS, PhD, Johnson, Douglas B., MD, Sullivan, Ryan J., MD, Boland, Genevieve M., MD, PhD, Si, Lu, MD

Get full text

Benefit, recurrence pattern, and toxicity to adjuvant anti-PD-1 monotherapy varies by ethnicity and melanoma subtype: An international multicenter cohort studyCapsule Summary by Xue Bai, MD, Aleigha R. Lawless, BS, Juliane A. Czapla, MS, Stefanie C. Gerstberger, MD, PhD, Benjamin C. Park, MD, Seungyeon Jung, BA, Rebecca Johnson, MN, Naoya Yamazaki, MD, PhD, Dai Ogata, MD, PhD, Yoshiyasu Umeda, MD, Caili Li, MB, Jun Guo, MD, PhD, Keith T. Flaherty, MD, Yasuhiro Nakamura, MD, PhD, Kenjiro Namikawa, MD, PhD, Georgina V. Long, MBBS, PhD, Alexander M. Menzies, MBBS, PhD, Douglas B. Johnson, MD, Ryan J. Sullivan, MD, Genevieve M. Boland, MD, PhD, Lu Si, MD

Get full text